{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:33:15Z","timestamp":1764084795660},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T00:00:00Z","timestamp":1396828800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Ethics"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>From an epidemiological perspective, the practice of universal vaccination of girls and young women in order to prevent human papilloma virus (HPV) infection and potential development of cervical cancer is widely accepted even though it may lead to the neglect of other preventive strategies against cervical cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>It is argued that removing the deterrent effect \u2013 the fear of developing cancer \u2013 could encourage teenage sex. This paper reflects on the ethical legitimacy of the universal vaccination of girls and young women against HPV infection, especially regarding safety issues, the need to vaccinate people who have opted to abstain from sex, the presumption of early onset of sexual relations, the commercial interests of the companies that manufacture the vaccine, and the recommendation of universal vaccination in males.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Based on the aforementioned information, we believe that the universal vaccination against HPV in young women is acceptable from an ethical point of view, given the medical advantages it presents.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1472-6939-15-29","type":"journal-article","created":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T20:03:52Z","timestamp":1396901032000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Ethical considerations of universal vaccination against human papilloma virus"],"prefix":"10.1186","volume":"15","author":[{"given":"Pedro","family":"Navarro-Illana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justo","family":"Aznar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"D\u00edez-Domingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,7]]},"reference":[{"issue":"Suppl 1","key":"267_CR1","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.jcv.2004.12.004","volume":"32","author":"A Molijn","year":"2005","unstructured":"Molijn A, Kleter B, Quint W, Van Doorn LJ: Molecular diagnosis of Human Papillomavirus (HPV) infections. J Clin Virol. 2005, 32 (Suppl 1): S43-51.","journal-title":"J Clin Virol"},{"key":"267_CR2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/00007435-200211000-00018","volume":"29","author":"L Manhart","year":"2002","unstructured":"Manhart L, Koutsky L: Do condoms prevent genital hpv infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis. 2002, 29: 725-735. 10.1097\/00007435-200211000-00018.","journal-title":"Sex Transm Dis"},{"key":"267_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/aje\/kwf180","volume":"157","author":"RL Winer","year":"2003","unstructured":"Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA: Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003, 157: 218-226. 10.1093\/aje\/kwf180.","journal-title":"Am J Epidemiol"},{"key":"267_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJM199802123380703","volume":"338","author":"GFY Ho","year":"1998","unstructured":"Ho GFY, Bierman R, Beardsley L, Chang CJ, Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998, 338: 423-428. 10.1056\/NEJM199802123380703.","journal-title":"N Engl J Med"},{"key":"267_CR5","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/infdis\/169.4.792","volume":"1 69","author":"M Davidson","year":"1994","unstructured":"Davidson M, Schnitzer PG, Bulkow LR, Parkinson AJ, Schloss ML, Fitzgerald MA, Knight JA, Murphy CM, Kiviat NB, Toomey KE, Reeves WC, Schmid DS, Stamm WE: The prevalence of cervical infection with human papillomaviruses and cervical dysplasia in Alaska native women. J Infect Dis. 1994, 1 69: 792-800.","journal-title":"J Infect Dis"},{"key":"267_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/00007435-199507000-00007","volume":"22","author":"JH Jamison","year":"1995","unstructured":"Jamison JH, Kaplan DW, Hamman R, Eagar R, Beach R, Douglas JM: Spectrum of genital human papillomavirus infection in a female adolescent population. Sex Transm Dis. 1995, 22: 236-243. 10.1097\/00007435-199507000-00007.","journal-title":"Sex Transm Dis"},{"issue":"4","key":"267_CR7","first-page":"38","volume":"27","author":"SK Kjaer","year":"2000","unstructured":"Kjaer SK, Svare EI, Worm AM, Walboomers JM, Meijer CJ, Van Den Brule AJ: Human papillomavirus infection in Danish female sex workers: decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis. 2000, 27 (4): 38-45.","journal-title":"Sex Transm Dis"},{"key":"267_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/01.olq.0000140012.02703.10","volume":"10","author":"SB Baldwin","year":"2004","unstructured":"Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Giuliano AR: Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Transm Dis. 2004, 10: 601-607.","journal-title":"Sex Transm Dis"},{"issue":"Suppl 1","key":"267_CR9","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.jcv.2004.12.006","volume":"32","author":"J Doorbar","year":"2005","unstructured":"Doorbar J: The Papillomavirus life cycle. J Clin Virol. 2005, 32 (Suppl 1): S7-15.","journal-title":"J Clin Virol"},{"key":"267_CR10","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1056\/NEJMp0806284","volume":"360","author":"MA Goldstein","year":"2009","unstructured":"Goldstein MA, Goodman A, Del Carmen MG, Wilbur DC: Case records of the Massachusetts General Hospital. Case 10\u20132009. A 23-year-old woman with an abnormal papanicolaou smear. N Engl J Med. 2009, 360: 1337-1344. 10.1056\/NEJMcpc0810837.","journal-title":"N Engl J Med"},{"issue":"4","key":"267_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Mu\u00f1oz N, Meijer CJ, Shah KV: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002, 55 (4): 244-265. 10.1136\/jcp.55.4.244. Review","journal-title":"J Clin Pathol"},{"issue":"Suppl 3","key":"267_CR12","first-page":"S3\/106","volume":"24","author":"M Stanley","year":"2006","unstructured":"Stanley M, Lowy DR, Frazer I: Chapter 12: Prophylactic HPV vaccines: underlying mechanisms. Vaccine. 2006, 24 (Suppl 3): S3\/106-113. Review","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"267_CR13","first-page":"S3\/1","volume":"24","author":"N Mu\u00f1oz","year":"2006","unstructured":"Mu\u00f1oz N, Castellsagu\u00e9 X, De Gonz\u00e1lez AB, Gissman L: Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006, 24 (Suppl 3): S3\/1-10.","journal-title":"Vaccine"},{"key":"267_CR14","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, Sanjos\u00e9 S, Herrero R, Castellsagu\u00e9 X, Shah KV, Snijders PJ, Meijer CJLM, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348: 518-527. 10.1056\/NEJMoa021641.","journal-title":"N Engl J Med"},{"key":"267_CR15","volume-title":"GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. International Agency for Research on Cancer. World Health Organization. IARC, WHO","author":"J Ferlay","year":"2004","unstructured":"Ferlay J, Bray F, Pisani P, Parkin DM: GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. International Agency for Research on Cancer. World Health Organization. IARC, WHO. 2004, IARC: Lyon"},{"key":"267_CR16","volume-title":"Cervical Cancer Incidence, Mortality and Prevalence Worldwide in 2008. International Agency for Research on Cancer. World Health Organization","author":"GLOBOCAN 2008","year":"2008","unstructured":"GLOBOCAN 2008: Cervical Cancer Incidence, Mortality and Prevalence Worldwide in 2008. International Agency for Research on Cancer. World Health Organization. 2008, Lyon: IARC, WHO, Available at: http:\/\/globocan.iarc.fr\/factsheet.asp (Accessed 31 July 2012)"},{"key":"267_CR17","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM199711063371904","volume":"337","author":"M Frisch","year":"1997","unstructured":"Frisch M, Glimelius B, van Den Brule AJ, Wohlfahrt J, Meijer CJLM, Walboomers JMM, Goldman S, Svensson C, Adami HO, Melbye M: Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 1997, 337: 1350-1358. 10.1056\/NEJM199711063371904.","journal-title":"N Engl J Med"},{"key":"267_CR18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1590\/S1020-49892012000600007","volume":"31","author":"CM Pierce Campbell","year":"2012","unstructured":"Pierce Campbell CM, Curado MP, Harlow SD, Solimans AS: Variation of cervical cancer incidence in Latin America and the Caribbean. Rev Panam Salud Publica. 2012, 31: 492-498. 10.1590\/S1020-49892012000600007.","journal-title":"Rev Panam Salud Publica"},{"key":"267_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0950268805005728","volume":"134","author":"CM Lowndes","year":"2006","unstructured":"Lowndes CM: Vaccines for cervical cancer. Epidemiol Infect. 2006, 134: 1-12. 10.1017\/S0950268805005728.","journal-title":"Epidemiol Infect"},{"key":"267_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1157\/13106938","volume":"129","author":"JA Navarro-Alonso","year":"2007","unstructured":"Navarro-Alonso JA, Bernal-Gonz\u00e1lez PJ, P\u00e9rez-Mart\u00edn JJ: Interrogantes en la Introducci\u00f3n de la Vacuna frente al Virus del Papiloma Humano en los Calendarios Sistem\u00e1ticos. Med Clin (Barc). 2007, 129: 55-60. 10.1157\/13106938.","journal-title":"Med Clin (Barc)"},{"key":"267_CR21","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","volume":"366","author":"GM Clifford","year":"2005","unstructured":"Clifford GM, Gallus S, Herrero R, Mu\u00f1oz N, Snijders PJF, Vaccarella S, Anh PTH, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjos\u00e9 S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJLM, Franceschi S, IARC HPV Prevalence Surveys Study Group: Worldwide distribution of human papillomavirus types in cytologically normal women in the international agency for research on cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005, 366: 991-998. 10.1016\/S0140-6736(05)67069-9.","journal-title":"Lancet"},{"key":"267_CR22","volume-title":"Detecci\u00f3n Precoz del C\u00e1ncer de C\u00e9rvix. Informe de Salud n\u00b0 72","author":"JC Ant\u00f3n Pascual","year":"2004","unstructured":"Ant\u00f3n Pascual JC, Salas TD: Detecci\u00f3n Precoz del C\u00e1ncer de C\u00e9rvix. Informe de Salud n\u00b0 72. 2004, Direcci\u00f3n General de Salud P\u00fablica. Generalitat Valenciana: Valencia"},{"issue":"3","key":"267_CR23","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/IGC.0000000000000084","volume":"24","author":"J Jeronimo","year":"2014","unstructured":"Jeronimo J, Bansil P, Lim J, Peck R, Paul P, Amador JJ, Mirembe F, Byamugisha J, Poli UR, Satyanarayana L, Asthana S, START-UP Study Group: A multicountry evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer. Int J Gynecol Cancer. 2014, 24 (3): 576-585. 10.1097\/IGC.0000000000000084.","journal-title":"Int J Gynecol Cancer"},{"key":"267_CR24","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1186\/1471-2407-12-551","volume":"12","author":"S Snellenberg","year":"2012","unstructured":"Snellenberg S, De Strooper LM, Hesselink AT, Meijer CJ, Snijders PJ, Heideman DA, Steenbergen RD: Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape. BMC Cancer. 2012, 12: 551-10.1186\/1471-2407-12-551.","journal-title":"BMC Cancer"},{"key":"267_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/oxfordjournals.jncimonographs.a003477","volume":"31","author":"X Castellsagu\u00e9","year":"2003","unstructured":"Castellsagu\u00e9 X, Mu\u00f1oz N: Chapter 3: cofactors in human papillomavirus carcinogenesis\u2014role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr. 2003, 31: 20-28. Review","journal-title":"J Natl Cancer Inst Monogr"},{"key":"267_CR26","volume-title":"Tobacco Smoke and Involuntary Smoking","author":"IARC Technical reports N3","year":"2004","unstructured":"IARC Technical reports N3: Tobacco Smoke and Involuntary Smoking. 2004, Lyon: IARC Press"},{"key":"267_CR27","first-page":"31","volume-title":"4\u00aa Monograf\u00eda de la Sociedad Espa\u00f1ola de Epidemiolog\u00eda. Virus del Papiloma Humano y C\u00e1ncer: epidemiolog\u00eda y prevenci\u00f3n","author":"FX Bosch Jos\u00e9","year":"2006","unstructured":"Bosch Jos\u00e9 FX, Diaz Sanchis M, de Sanjos\u00e9 Llongueras S, Font Marimon R, Castellsagu\u00e9 Piqu\u00e9 X, Albero Abril G, Lloveras Rubio B, Klaustermeier Lloveras J, Moreno Aguado V: Epidemiolog\u00eda de las infecciones por el virus del papiloma humano (HPV): riesgo de carcinoma c\u00e9rvico-uterino y otros tumores anogenitales. Nuevas opciones preventivas. 4\u00aa Monograf\u00eda de la Sociedad Espa\u00f1ola de Epidemiolog\u00eda. Virus del Papiloma Humano y C\u00e1ncer: epidemiolog\u00eda y prevenci\u00f3n. Edited by: De Sanjos\u00e9 S, Garc\u00eda AM. 2006, Madrid: EMISA, 31-"},{"key":"267_CR28","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/aje\/kwf098","volume":"156","author":"M Lehtinen","year":"2002","unstructured":"Lehtinen M, Koskela P, Jellum E, Bloigu A, Anttila T, Hallmans G, Luukkaala T, Thoresen S, Youngman L, Dillner J, Hakama M: Herpes simplex virus and risk for cervical cancer: a longitudinal nested case\u2013control study in the Nordic Countries. Am J Epidemiol. 2002, 156: 687-692. 10.1093\/aje\/kwf098.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"267_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2165\/11591560-000000000-00000","volume":"30","author":"N Demarteau","year":"2012","unstructured":"Demarteau N, Breuer T, Standaert B: Selecting a mix of prevention strategies against cervical cancer for maximum efficiency with an optimization program. Pharmacoeconomics. 2012, 30 (4): 337-353. 10.2165\/11591560-000000000-00000.","journal-title":"Pharmacoeconomics"},{"key":"267_CR30","doi-asserted-by":"publisher","first-page":"e4168","DOI":"10.1136\/bmj.e4168","volume":"344","author":"P Oakeshott","year":"2012","unstructured":"Oakeshott P, Aghaizu A, Reid F, Howell-Jones R, Hay PE, Sadiq ST, Lacey CJ, Beddows S, Soldan K: Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study. BMJ. 2012, 344: e4168-10.1136\/bmj.e4168.","journal-title":"BMJ"},{"issue":"7","key":"267_CR31","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0025-7753(08)72246-2","volume":"131","author":"MA Mart\u00ednez-Gonz\u00e1lez","year":"2008","unstructured":"Mart\u00ednez-Gonz\u00e1lez MA, Carlos S, De Irala J: Human papillomavirus vaccine: optimism versus prudence. Med Clin. 2008, 131 (7): 256-263. 10.1016\/S0025-7753(08)72246-2.","journal-title":"Med Clin"},{"issue":"9574","key":"267_CR32","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","volume":"369","author":"EA Joura","year":"2007","unstructured":"Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Garland SM, Harper DM, Tang GWK, Ferris DG, Steben M, Jones RW, Bryan J, Taddeo FJ, Bautista OM, Esser MT, Sings HL, Nelson M, Boslego JW, Sattler C, Barr E, Paavonen J: Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet. 2007, 369 (9574): 1693-1702. 10.1016\/S0140-6736(07)60777-6.","journal-title":"Lancet"},{"key":"267_CR33","first-page":"63","volume":"37","author":"J Cort\u00e9s","year":"2010","unstructured":"Cort\u00e9s J, Martin\u00f3n F, Ferret G, Garc\u00eda E, Cajal JM R y, Garrido R, Miranda P, Dexeus D, Gil A, Cisterna R: Vacunas Frente al Virus del Papiloma Humano: Actualizaci\u00f3n. Clin Invest Gin Obst. 2010, 37: 63-74.","journal-title":"Clin Invest Gin Obst"},{"key":"267_CR34","first-page":"31","volume":"1","author":"A L\u00f3pez","year":"2006","unstructured":"L\u00f3pez A, Lizano M: C\u00e1ncer Cervicouterino y el Virus de Papiloma Humano la Historia que No Termina. Instituto Nacional de Cancerolog\u00eda de M\u00e9xico. 2006, 1: 31-55.","journal-title":"Instituto Nacional de Cancerolog\u00eda de M\u00e9xico"},{"key":"267_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1503\/cmaj.070948","volume":"177","author":"L Rambout","year":"2007","unstructured":"Rambout L, Hopkins L, Hutton B, Ferguson D: Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials. CMAJ. 2007, 177: 469-479. 10.1503\/cmaj.070948.","journal-title":"CMAJ"},{"key":"267_CR36","volume-title":"WHO weekly epidemiological record N\u00ba 5, 2009, 84th year, 37\u201340","author":"Who.org","year":"2009","unstructured":"Who.org: WHO weekly epidemiological record N\u00ba 5, 2009, 84th year, 37\u201340. 2009, Geneve, Available at: http:\/\/www.who.int\/wer\/2009\/wer8405.pdf (Accessed on 31 July 2012)"},{"key":"267_CR37","first-page":"17","volume-title":"Cap\u00edtulo 3: La Infecci\u00f3n por VPH en Poblaci\u00f3n General y de Alto Riesgo de C\u00e1ncer de Cuello Uterino en Espa\u00f1a. En: Ministerio de Sanidad y Consumo. \u201cVirus del Papiloma Humano. Situaci\u00f3n Actual, Vacunas y Perspectivas de su Utilizaci\u00f3n\u201d","author":"J Del Amo-Valero","year":"2007","unstructured":"Del Amo-Valero J: Cap\u00edtulo 3: La Infecci\u00f3n por VPH en Poblaci\u00f3n General y de Alto Riesgo de C\u00e1ncer de Cuello Uterino en Espa\u00f1a. En: Ministerio de Sanidad y Consumo. \u201cVirus del Papiloma Humano. Situaci\u00f3n Actual, Vacunas y Perspectivas de su Utilizaci\u00f3n\u201d. 2007, 17-Available at: http:\/\/www.aepcc.org\/download\/documentos\/profesionales\/3-msc_hpv_doc_vacunas_feb-07.pdf (Accessed on 31 July 2012)"},{"key":"267_CR38","first-page":"33","volume-title":"Cap\u00edtulo 5: VACUNAS FRENTE AL VPH. Pach\u00f3n et al. \u201cSituaci\u00f3n Actual, Vacunas y Perspectivas de su Utilizaci\u00f3n\u201d","author":"F Salmer\u00f3n-Garc\u00eda","year":"2007","unstructured":"Salmer\u00f3n-Garc\u00eda F, Portela-Moreira F, Soler-Soner\u00eda M: Cap\u00edtulo 5: VACUNAS FRENTE AL VPH. Pach\u00f3n et al. \u201cSituaci\u00f3n Actual, Vacunas y Perspectivas de su Utilizaci\u00f3n\u201d. 2007, 33-Available at: http:\/\/www.aepcc.org\/download\/documentos\/profesionales\/3-msc_hpv_doc_vacunas_feb-07.pdf (Accessed on 31 July 2012)"},{"key":"267_CR39","unstructured":"Gardasil\u00ae DATA SHEET: EMEA, European Medicines Agency. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000703\/WC500021142.pdf (Accessed on 31 July 2012)"},{"key":"267_CR40","unstructured":"WHO\/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre): Human Papillomavirus. and Related Cancers in New Zealand. Summary Report 2010. [Accessed on 11 March 2014]. Available at http:\/\/www.who.int\/hpvcentre"},{"key":"267_CR41","first-page":"1","volume":"1","author":"NP Klein","year":"2012","unstructured":"Klein NP, Hansen J, Chao C, Velicer C, Emery M, Slezak J, Lewis N, Deosaransingh K, Sy L, Ackerson B, Cheetham TC, Liaw KL, Takhar H, Jacobsen SJ: Safety of quadrivalent human papillomavirus vaccine administered routinely to females. Arch Pediatr Adolesc Med. 2012, 1: 1-9.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"267_CR42","volume-title":"Vacunaci\u00f3n frente al Virus del Papiloma Humano","author":"Documento de Consenso de Sociedades Cient\u00edficas Espa\u00f1olas","year":"2011","unstructured":"Documento de Consenso de Sociedades Cient\u00edficas Espa\u00f1olas: Vacunaci\u00f3n frente al Virus del Papiloma Humano. 2011, Coord. Javier Cort\u00e9s, Available at: http:\/\/vacunasaep.org\/sites\/vacunasaep.org\/files\/VPH_Consenso_Sociedades_2011.pdf [Accessed on 25 October 2012]"},{"key":"267_CR43","doi-asserted-by":"publisher","first-page":"952","DOI":"10.4161\/hv.7.9.15995","volume":"7","author":"JS Smith","year":"2011","unstructured":"Smith JS, Brewer NT, Chang Y, Liddon N, Guerry S, Pettigrew E, Markowitz LE, Gottlieb SL: Acceptability of school requirements for human papillomavirus vaccine. Hum Vaccin. 2011, 7: 952-957. 10.4161\/hv.7.9.15995.","journal-title":"Hum Vaccin"},{"key":"267_CR44","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/jmv.23282","volume":"84","author":"X Castellsagu\u00e9","year":"2012","unstructured":"Castellsagu\u00e9 X, Ifner T, Roura E, Vidart JA, Kjaer SK, Bosch FX, Mu\u00f1oz N, Palacios S, San Martin Rodriguez M, Serradell L, Torcel-Pagnon L, Cortes J, CLEOPATRE Spain Study Group: Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study. J Med Virol. 2012, 84: 947-956. 10.1002\/jmv.23282.","journal-title":"J Med Virol"},{"key":"267_CR45","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","volume":"364","author":"DM Harper","year":"2004","unstructured":"Harper DM, El F, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, Roteli-Martins CM, Teixeira J, Blatter MM, Korn AP, Quint W, Dubin G, GlaxoSmithKline HPV Vaccine Study Group: Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet. 2004, 364: 1757-1765. 10.1016\/S0140-6736(04)17398-4.","journal-title":"Lancet"},{"key":"267_CR46","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/00128360-200407000-00005","volume":"8","author":"K Davis","year":"2004","unstructured":"Davis K, Dickman ED, Ferris D, Dias JK: Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis. 2004, 8: 188-194. 10.1097\/00128360-200407000-00005.","journal-title":"J Low Genit Tract Dis"},{"issue":"7","key":"267_CR47","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/jama.2009.1179","volume":"302","author":"SM Rothman","year":"2009","unstructured":"Rothman SM, Rothman DJ: Marketing HPV vaccine: implications for adolescent health and medical professionalism. JAMA. 2009, 302 (7): 781-6. 10.1001\/jama.2009.1179.","journal-title":"JAMA"},{"key":"267_CR48","first-page":"116","volume":"1994","author":"SMA Vaccine","year":"2006","unstructured":"Vaccine SMA: 1: 16\u201322 AND Stanley MA: In: Stern PL. Stanley MA: Oxford University Press. 2006, 1994: 116-131.","journal-title":"Stanley MA: Oxford University Press"},{"key":"267_CR49","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3201\/eid1011.040222","volume":"10","author":"AV Taira","year":"2004","unstructured":"Taira AV, Neukermans CP, Sanders GD: Evaluating human papillomavirus vaccination programs. Emerg Infect Dis. 2004, 10: 1915-1923. 10.3201\/eid1011.040222.","journal-title":"Emerg Infect Dis"},{"key":"267_CR50","first-page":"1705","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","unstructured":"Centers for Disease Control and Prevention (CDC): Recommendations on the use of quadrivalent human papillomavirus vaccine in males\u2014Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011, 60: 1705-1708.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"267_CR51","volume-title":"Theologiae Moralis Summa","author":"M Zalla","year":"1952","unstructured":"Zalla M: Theologiae Moralis Summa. 1952, Madrid: BAC, I, 209, n\u00ba189"},{"key":"267_CR52","first-page":"356","volume":"87","author":"KP La","year":"1965","unstructured":"La KP: Determination du Bien et du Mal Moral par la Pr\u00edncipe du Doble Effect. Nouv Rev Th\u00e9olo. 1965, 87: 356-376.","journal-title":"Nouv Rev Th\u00e9olo"},{"key":"267_CR53","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1542\/peds.2012-1516","volume":"130","author":"RA Bednarczyk","year":"2012","unstructured":"Bednarczyk RA, Davis R, Ault K, Orenstein W, Omer SB: Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds. Pediatrics. 2012, 130: 798-805. 10.1542\/peds.2012-1516.","journal-title":"Pediatrics"},{"key":"267_CR54","first-page":"284","volume":"2","author":"J Aznar","year":"1998","unstructured":"Aznar J: Sida: Transmisi\u00f3n y Aspectos \u00c9ticos. Cuadernos de Bio\u00e9tica. 1998, 2: 284-303.","journal-title":"Cuadernos de Bio\u00e9tica"},{"key":"267_CR55","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0277-9536(96)00258-4","volume":"44","author":"SD Pinkerton","year":"1997","unstructured":"Pinkerton SD, Abramson PR: Effectiveness of condoms in preventing HIV transmission. Soc Sci Med. 1997, 44: 1303-1312. 10.1016\/S0277-9536(96)00258-4.","journal-title":"Soc Sci Med"},{"key":"267_CR56","doi-asserted-by":"publisher","first-page":"272","DOI":"10.2307\/2991537","volume":"31","author":"KR Davis","year":"1999","unstructured":"Davis KR, Weller SC: The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam Plann Perspect. 1999, 31: 272-279. 10.2307\/2991537.","journal-title":"Fam Plann Perspect"},{"issue":"8","key":"267_CR57","first-page":"611","volume":"344","author":"HW Haverkos","year":"2001","unstructured":"Haverkos HW, Chung RC: AIDS among heterosexuals in surveillance reports. N Engl J Med. 2001, 344 (8): 611-613.","journal-title":"N Engl J Med"},{"key":"267_CR58","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3109\/00365548809032444","volume":"20","author":"PC G\u00f8tzsche","year":"1988","unstructured":"G\u00f8tzsche PC, H\u00f8rding M: Condoms to prevent HIV transmission do not imply truly safe sex. Scand J Infect Dis. 1988, 20: 233-234. 10.3109\/00365548809032444.","journal-title":"Scand J Infect Dis"},{"key":"267_CR59","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1001\/jama.1988.03720160048029","volume":"259","author":"N Hearst","year":"1988","unstructured":"Hearst N, Hulley SB: Preventing the heterosexual spread of AIDS. Are we giving our patients the best advice?. JAMA. 1988, 259: 2428-2432. 10.1001\/jama.1988.03720160048029.","journal-title":"JAMA"},{"key":"267_CR60","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2105\/AJPH.78.1.52","volume":"78","author":"PJ Feldblum","year":"1988","unstructured":"Feldblum PJ, Fortney JA: Condoms, spermicides, and the transmission of human immunodeficiency virus: a review of the literature. Am J Public Health. 1988, 78: 52-54. 10.2105\/AJPH.78.1.52.","journal-title":"Am J Public Health"},{"key":"267_CR61","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1748-720X.2008.00282.x","volume":"36","author":"G Javitt","year":"2008","unstructured":"Javitt G, Berkowitz D, Gostin LO: Assessing mandatory HPV vaccination: who should call the shots?. J Law Med Ethics. 2008, 36: 384-395. 10.1111\/j.1748-720X.2008.00282.x.","journal-title":"J Law Med Ethics"},{"key":"267_CR62","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/LGT.0b013e3181b0fad4","volume":"14","author":"L Horn","year":"2010","unstructured":"Horn L, Howards C, Waller J, Ferris DG: Opinions of parents about school-entry mandates for the human papillomavirus vaccine. J Low Genit Tract Dis. 2010, 14: 43-48. 10.1097\/LGT.0b013e3181b0fad4.","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"267_CR63","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1370\/afm.723","volume":"5","author":"AL Sussman","year":"2007","unstructured":"Sussman AL, Helitzer D, Sanders M, Urquieta B, Salvador M, Ndiaye K: HPV and cervical cancer prevention counseling with younger adolescents: implications for primary care. Ann Fam Med. 2007, 5 (4): 298-304. 10.1370\/afm.723.","journal-title":"Ann Fam Med"}],"container-title":["BMC Medical Ethics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6939-15-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6939-15-29\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6939-15-29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6939-15-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:27:22Z","timestamp":1630553242000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedethics.biomedcentral.com\/articles\/10.1186\/1472-6939-15-29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,7]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["267"],"URL":"https:\/\/doi.org\/10.1186\/1472-6939-15-29","relation":{},"ISSN":["1472-6939"],"issn-type":[{"value":"1472-6939","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,7]]},"assertion":[{"value":"17 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"29"}}